Clinical Trials
3 trialsNCT05077215 2025-12-08
Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer
Evergreen Therapeutics, Inc.
Phase 3 Not yet recruiting
NCT05106127 2025-12-08
Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem
Evergreen Therapeutics, Inc.
Phase 2 Not yet recruiting
NCT06046274 2024-04-30
GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer
Genmab
Phase 2 Withdrawn